Beneficial effects of Terminalia arjuna in coronary artery disease.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/9505018
Conclusion of this study
Prolonged administration of T. arjuna did not show any adverse effects on renal, hepatic and haematological parameters. The potential of T. arjuna to improve left ventricular ejection fraction and reduce left ventricular mass in coronary artery disease needs to be harnessed.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
Cardiovascular System |